v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Feb. 28, 2026
Feb. 28, 2025
Cash flows from operating activities    
Net loss from continuing operations $ (1,160,176) $ (1,181,136)
Net loss from discontinued operations (25,014)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation 8,786 3,146
Stock based compensation expense 103,125
Changes in operating assets and liabilities:    
Deferred research and development costs (3,587) (18,039)
Prepaid expenses and other assets (63,192) 624,233
Accounts payable and accrued expenses 73,377 4,402
Related party payable 10,835 37,357
Net cash used in operating activities (1,133,957) (451,926)
Cash flows from investing activities    
Redemption of short-term investments 3,000,000
Capital expenditures (29,864)
Net cash provided by investing activities (29,864) 3,000,000
Net increase in cash and cash equivalents (1,163,821) 2,548,074
Cash  and cash equivalents at beginning of period 6,555,642 1,249,446
Cash and cash equivalents at end of period $ 5,391,821 $ 3,797,520